Iain McInnes - Dissemin

Language
Login

All papers authored by Iain McInnes

This paper is made freely available by the publisher.

2023 Christina Charles-Schoeman

ORCID

ORCID

, Iain B. McInnes

ORCID

, Eduardo Mysler, Peter Nash

ORCID

, Kunihiro Yamaoka

ORCID

, Ralph Lippe, Nasser Khan, Anna K. Shmagel, Hannah Palac, Jessica Suboticki, Jeffrey R. Curtis

ORCID

MACE and VTE across upadacitinib clinical trial programmes in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis

Download from doi.org

This paper is made freely available by the publisher.

2022 Kastriot Kastrati

ORCID

, Daniel Aletaha

ORCID

, Gerd R. Burmester

ORCID

, Eva Chwala, Christian Dejaco

ORCID

, Maxime Dougados

ORCID

, Iain B. McInnes

ORCID

, Angelo Ravelli

ORCID

, Naveed Sattar, Tanja A. Stamm

ORCID

, Tsutomu Takeuchi

ORCID

, Michael Trauner, Desirée van der Heijde

ORCID

, Marieke J. H. Voshaar, Kevin Winthrop

ORCID

and 2 other authors

A systematic literature review informing the consensus statement on efficacy and safety of pharmacological treatment with interleukin-6 pathway inhibition with biological DMARDs in immune-mediated inflammatory diseases

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Iain B. McInnes

ORCID

, Proton Rahman, Alice B. Gottlieb, Elizabeth C. Hsia, Alexa P. Kollmeier, Xie L. Xu, Yusang Jiang, Shihong Sheng, May Shawi, Soumya D. Chakravarty

ORCID

, Désirée van der Heijde, Philip J. Mease

ORCID

Long‐Term Efficacy and Safety of Guselkumab, a Monoclonal Antibody Specific to the p19 Subunit of Interleukin‐23, Through Two Years: Results From a Phase III , Randomized, Double‐Blind , Placebo‐Controlled Study Conducted in Biologic‐Naive Patients With Active Psoriatic Arthritis

Upload

This paper was not found in any repository, but could be made available legally by the author.

2019 Stefan Siebert

ORCID

, Kristen Sweet, Bidisha Dasgupta, Kim Campbell, Iain B. McInnes

ORCID

, Matthew J. Loza

ORCID

Responsiveness of Serum C‐Reactive Protein, Interleukin‐17A, and Interleukin‐17F Levels to Ustekinumab in Psoriatic Arthritis: Lessons From Two Phase III, Multicenter, Double‐Blind, Placebo‐Controlled Trials

Upload

Missing publications? Search for publications with a matching author name.